Related Experiment Video
Updated: Jun 26, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
Gastrointestinal pathology in a mouse model of mucopolysaccharidosis type IIIA
Ainslie L K Derrick Roberts1, Gordon S Howarth, Wan Chin Liaw
1Department of Genetic Medicine, Matrix Biology Unit, Children, Youth and Women's Health Service, North Adelaide, SA, Australia.
Abstract:
Mucopolysaccharidosis type IIIA (MPS IIIA) is a lysosomal storage disorder caused by a deficiency in sulphamidase (NS), a lysosomal enzyme required for the degradation of heparan sulphate glycosaminoglycans (gags). The MPS IIIA mouse is a naturally occurring model that accurately reflects the human pathology and disease course. It displays primarily central nervous system pathology accompanied by widespread accumulation of gag in somatic tissues. MPS IIIA mice exhibit greater bodyweight gain than normal littermates and attain a higher mature bodyweight. In this study, gastrointestinal morphology and function was characterised in the IIIA mouse. Stomach and duodenum weight increased in MPS IIIA mice and duodenum length also increased. An increased submucosal thickness was observed in MPS IIIA intestine compared to normal mice and lysosomal storage of gag was observed in this region. Storage was also observed in the lamina propria of the villus tip. All other morphometric measurements including villus height and crypt depth fell within the normal range. The gastric emptying half-life of solid and liquid meals decreased with age in normal mice whereas the T(1/2) of solid meals did not alter with age in MPS IIA mice such that they were elevated above normal by 38 weeks of age. Sucrase activity was higher than normal in MPS IIIA at all ages tested. These abnormalities in GI structure and function observed in MPS IIIA may contribute to weight gain in this disorder.
Insights
Mucopolysaccharidosis type IIIA (MPS IIIA) in mice shows gastrointestinal changes, including increased stomach and duodenum size. These GI abnormalities may contribute to the increased body weight observed in MPS IIIA mice.
Area of Science:
- Biochemistry
- Genetics
- Pathology
Background:
- Mucopolysaccharidosis type IIIA (MPS IIIA) is a genetic lysosomal storage disorder.
- It results from a deficiency in sulphamidase (NS), impairing heparan sulphate glycosaminoglycan (GAG) degradation.
- MPS IIIA mouse models exhibit CNS pathology and GAG accumulation in tissues.
Purpose of the Study:
- To characterize gastrointestinal (GI) morphology and function in the MPS IIIA mouse model.
- To investigate potential links between GI abnormalities and weight gain in MPS IIIA.
Main Methods:
- Comparative analysis of GI tract morphology in MPS IIIA and wild-type mice.
- Assessment of gastric emptying rates for solid and liquid meals.
- Measurement of sucrase enzyme activity in the GI tract.
Main Results:
- MPS IIIA mice showed increased stomach and duodenum weight and length.
- Increased submucosal thickness and GAG storage were observed in the MPS IIIA intestine.
- Gastric emptying of solid meals was altered with age in MPS IIIA mice, and sucrase activity was elevated.
Conclusions:
- MPS IIIA mice exhibit distinct GI structural and functional alterations.
- These GI abnormalities are potential contributors to the characteristic weight gain in MPS IIIA.
- The MPS IIIA mouse serves as a valuable model for studying GI manifestations of lysosomal storage disorders.
